Microhaematuria
https://doi.org/10.21886/2308-6424-2025-13-3-7-9
Abstract
The May 2025 updates to the American Urological Association (AUA) and the Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) Microhaematuria (MH) Guideline 2020 have been published. The updates are based on the latest publications of the last five years and mainly address diagnostic programmes for bladder, upper urinary tract and renal parenchyma cancers. The importance of urinary markers, endoscopy, ultrasound and MRI to improve the diagnostic capabilities of tumour diseases is evaluated.
Supporting agencies: The study was not sponsored
About the Author
M. I. Kogan
Rostov State Medical University
Russian Federation
Competing Interests:
Russian Federation
Mikhail I. Kogan — Dr.Sc.(Med), Full Prof., Hons. Sci. of the Russian Federation.
Rostov-on-Don
Competing Interests:
The author declares no conflict of interest
References
1. Barocas DA, Lotan Y, Matulewicz RS, Raman JD, Westerman ME, Kirkby E, Pak LJ, Souter L. Updates to Microhematuria: AUA/SUFU Guideline (2025). J Urol. 2025;213(5):547-557. DOI: 10.1097/JU.0000000000004490
2. Barocas DA, Boorjian SA, Alvarez RD, Downs TM, Gross CP, Hamilton BD, Kobashi KC, Lipman RR, Lotan Y, Ng CK, Nielsen ME, Peterson AC, Raman JD, Smith-Bindman R, Souter LH. Microhematuria: AUA/SUFU Guideline. J Urol. 2020;204(4):778-786. DOI: 10.1097/JU.0000000000001297
3. Sancı A, Özkaya MF, Kubilay E, Gokce Mİ, Süer E, Gülpinar O, Baltacı S, Turkolmez K. Individual-risk-score for urinary tract malignancy in patients with microscopic hematuria. Int J Clin Pract. 2021;75(10):e14662. DOI: 10.1111/ijcp.14662
Review
For citations:
Kogan M.I. Microhaematuria. Urology Herald. 2025;13(3):7-9. (In Russ.) https://doi.org/10.21886/2308-6424-2025-13-3-7-9
Views:
648
Email this article 